Prologis invests £500m into Cambridge's life sciences sector

A major development has been announced as Prologis, a property developer esteemed in Silicon Valley, sets to inject £500 million into the Cambridge Biomedical Campus, thereby expanding it by 115,000 sq ft. The substantial investment follows Chancellor Rachel Reeves' broader economic strategy to rejuvenate Britain's economy by drawing in private investment, specifically into fast-growing sectors like life sciences. The expansion is expected to fulfill the critical demand for lab space in the Cambridge area, renowned for its robust life sciences sector, and generate over 2,120 high-skilled jobs while contributing significantly to the UK's economy. The venture aligns with the administration's goal, as evidenced in the recent Autumn budget, of bolstering the life sciences sector, backed by £520 million from a new manufacturing fund. This strategic partnership forms a part of Prologis’ commitment to match governmental aims of leveraging Foreign Direct Investment to support sustainable growth, while demonstrating the government's alignment with the corporate sector to spur economic progress and scientific advancement in the UK.